isoalantolactone has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hui, XG; Huo, L; Li, WH; Li, XB; Liang, J; Ma, T; Peng, W; Sun, DX; Sun, ZQ; Wu, ZC; Zhang, Y | 1 |
| Choi, SJ; Kang, HJ; Kim, HJ; Kim, JS; Lee, IA; Lim, JS; Lim, SS; Park, J; Park, JH; Seo, JY | 1 |
2 other study(ies) available for isoalantolactone and Liver Neoplasms
| Article | Year |
|---|---|
Antiproliferative effects of isoalantolactone in human liver cancer cells are mediated through caspase-dependent apoptosis, ROS generation, suppression of cell migration and invasion and targeting Ras/Raf/MEK signalling pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Reactive Oxygen Species; Sesquiterpenes | 2022 |
Isoalantolactone from Inula helenium caused Nrf2-mediated induction of detoxifying enzymes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzymes; Fruit; Hep G2 Cells; Humans; Inactivation, Metabolic; Inula; Liver Neoplasms; Mice; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Phytotherapy; Plant Extracts; Plant Roots; Sesquiterpenes | 2009 |